Burgess Michael F. 4
4 · SpringWorks Therapeutics, Inc. · Filed Jul 20, 2022
Insider Transaction Report
Form 4
Burgess Michael F.
Head of Research & Development
Transactions
- Tax Payment
Common Stock
2022-07-18$28.47/sh−3,103$88,342→ 49,584 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person.